Status:
UNKNOWN
AR, IGF-IR, IR and Peripheral Artery Disease
Lead Sponsor:
University of Catanzaro
Conditions:
Androgen Receptor Abnormal
Insulin-Like Growth Factor I Deficiency
Eligibility:
MALE
18+ years
Brief Summary
Peripheral artery Disease (PAD) is a major cardiovascular disease that can impair quality of life (QoL). It affects more often male patients and its pathophysiology is not completely known. Probably a...
Detailed Description
Peripheral artery disease (PAD) of lower limbs is one of the most common clinical manifestation of atherosclerosis and can be considered a major cardiovascular disease with important morbidity and mor...
Eligibility Criteria
Inclusion
- Male patients with peripheral artery disease (PAD) eligible to receive arterial reconstructive open surgery.
Exclusion
- active malignancy
- advanced liver disease
- advanced heart disease
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04710186
Start Date
August 1 2018
End Date
March 1 2021
Last Update
January 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Magna Graecia of Catanzaro
Catanzaro, Italy, 88100